Supernus Pharmaceuticals, Inc. (SUPN)
50.80
+0.26
(+0.51%)
USD |
NASDAQ |
Apr 07, 13:55
Supernus Pharmaceuticals Price : 50.80 for April 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 174.46 |
| BridgeBio Pharma, Inc. | 71.37 |
| Corcept Therapeutics, Inc. | 41.57 |
| Catalyst Pharmaceuticals, Inc. | 25.10 |
| Cytokinetics, Inc. | 65.78 |
Price Related Metrics
| PS Ratio | 4.004 |
| Price to Book Value | 2.758 |
| Price to Free Cash Flow | 62.59 |
| Earnings Yield | -1.34% |
| Market Cap | 2.925B |